ECOR

Healthcare Medical Devices

electroCore, Inc.

$10.14
-0.26 -2.52% today

Price History

Not enough data

Key Stats

Market Cap
91.42M
Avg Volume
88,850
EPS
-$1.65
52W High
$12.70
52W Low
$4.41
Div. Yield
0.0%

Analyst Ratings

Buy
1
Str Buy
4
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
-18.44
P/B Ratio
-32.71
P/S Ratio
2.47
EV/EBITDA
-6.66
EV/Revenue
2.46

Margins

Gross Margin 87.1%
Operating Margin (29.3%)
Net Margin (40.0%)
EBITDA Margin (37.0%)

Growth & Returns

Revenue Growth (YoY)
28.0%
Return on Assets
(55.0%)

Liquidity & Leverage

Current Ratio
1.21
Quick Ratio
0.94
Total Cash
10.04M
Total Debt
9.56M

About

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

www.electrocore.com